TELO
NASDAQ · Pharmaceuticals
Telomir Pharmaceuticals Inc
$1.17
-0.01 (-0.43%)
Open$1.18
Previous Close$1.17
Day High$1.18
Day Low$1.16
52W High$2.09
52W Low$0.89
Volume—
Avg Volume71.3K
Market Cap80.47M
P/E Ratio—
EPS$-0.29
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.55M | 10.11M | 8.56M |
| Net Income | 1.76M | 2.03M | 1.53M |
| Profit Margin | 18.4% | 20.1% | 17.9% |
| EBITDA | 2.43M | 2.63M | 2.21M |
| Free Cash Flow | 1.02M | 1.59M | 1.30M |
| Rev Growth | -2.0% | +7.8% | +19.7% |
| Debt/Equity | 0.60 | 0.70 | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |